oxazoles has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeghate, E; Csekő, K; Dányádi, B; Deres, L; Ferdinandy, P; Gábriel, R; Halmosi, R; Helyes, Z; Horváth, ÁI; Kőszegi, T; Kovács-Valasek, A; Mátyus, P; Pintér, E; Sághy, É; Szabadfi, K; Tékus, V; Varga, ZV | 1 |
1 other study(ies) available for oxazoles and Diabetic Retinopathy
| Article | Year |
|---|---|
Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
Topics: Amine Oxidase (Copper-Containing); Analgesics; Animals; Cell Adhesion Molecules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hydrazines; Insulin; Insulin-Secreting Cells; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oximes; Rats; Rats, Sprague-Dawley; Streptozocin | 2021 |